Article
Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes
1 Jan 2012
Abstract excerpt
Hematogenous metastasis, the process of cancer cell migration from a primary to distal location via the bloodstream, typically leads to a poor patient prognosis. Selectin proteins hold promise in delivering drug-containing nanocarriers to circulating tumor cells (CTCs) in the bloodstream, due to their rapid, force-dependent binding kinetics. However, it is challenging to deliver such nanocarriers while avoiding...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
